Helex is a startup based in the United States, most recent round Seed.
Helex is a company headquartered in the United States. Its most recent tracked round is Seed.
Helex develops genomic medicines using proprietary lipid nanoparticle delivery and gene editing technologies to create targeted non-viral therapies for genetic kidney diseases such as Autosomal Dominant Polycystic Kidney Disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.